Abstract
Deleterious impacts of major mutations can be ameliorated by stabilising selection acting on modifier genes. We hypothesise that a new hyperactive circling mouse (counterspin: Cr) arises when modifier genes inadvertently selected to ameliorate the negative impacts of a growth hormone transgenic insertion segregate into the normal genetic background that lacks the transgene. We hypothesise that such modifiers generate a phenotype “mirror image” to the transgenics on the otherwise normal background. We highlight this by testing a priori hypotheses that counterspin and transgenic growth hormone mice deviate oppositely from normal mice across a broad spectrum of characteristics. Results spanning growth, sensorimotor performance, cognition and striatal neurotransmitters provide strong circumstantial evidence for the hypothesis. In a more direct test for selection in the transgenic mice, we found that those examined in 2008 slept ~3 h/d less than they did 14 years ago (P < 0.0005). This is a profound change strongly supporting the reality of modifier selection in these mice. Our results highlight that modifiers may act powerfully on genetically engineered constructs given a genetically variable background. Furthermore, we suggest that modifier selection might provide a novel method for deriving genetic models, and specifically, models phenotypically opposite to engineered constructs or natural mutations.
Similar content being viewed by others
References
Anisman, H., Hayley, S., Kelly, O., Borowski, T., & Merali, Z. (2001). Psychogenic, neurogenic, and systemic stressor effects on plasma corticosterone and behavior: Mouse strain-dependent outcomes. Behavioral Neuroscience, 115, 443–454. doi:10.1037/0735-7044.115.2.443.
Aspide, R., Carnevale, U. A. G., Sergeant, J. A., & Sadile, A. G. (1998). Non-selective attention and nitric oxide in putative animal models of Attention-Deficit Hyperactivity Disorder. Behavioural Brain Research, 95, 123–133. doi:10.1016/S0166-4328(97)00217-9.
Baldwin, J. M. (1902). Development and evolution. New York: MacMillan & Co.
Bao, L., Avshalumov, M. V., & Rice, M. E. (2005). Partial mitochondrial inhibition causes striatal dopamine release suppression and medium spiny neuron depolarization via H2O2 elevation, but not ATP depletion. The Journal of Neuroscience, 25, 10029–10040. doi:10.1523/JNEUROSCI.2652-05.2005.
Barsh, G. S., & Schwartz, M. W. (2002). Genetic approaches to studying energy balance: Perception and integration. National Review, 3, 589–600. doi:10.1038/nrn902.
Bartke, A. (2003). Can growth hormone (GH) accelerate aging? Evidence from GH-transgenic mice. Neuroendocrinology, 78, 210–216. doi:10.1159/000073704.
Bartke, A., Cecim, M., Tang, K., Steger, A. W., Chandrashekar, V., & Turyn, D. (1994). Neuroendocrine and reproductive consequences of overexpression of growth hormone in transgenic mice. Experimental Biology and Medicine, 206, 345–357.
Bartke, A., Chandrashekar, V., Turyn, T., Steger, R. W., Debeljuk, L., Winters, T. A., et al. (1999). Minireview: Effects of growth hormone overexpression and growth hormone resistance on neuroendocrine and reproductive functions in transgenic and knock-out mice. Experimental Biology and Medicine, 222, 113–123. doi:10.1046/j.1525-1373.1999.d01-121.x.
Belforte, J. E., Magarinos-Azcone, C., Armando, I., Buno, W., & Pazo, J. H. (2001). Pharmacological involvement of the calcium blocker flunarizine in dopamine transmission at the striatum. Parkinsonism & Related Disorders, 8, 33–40. doi:10.1016/S1353-8020(01)00006-2.
Belforte, J. E., & Pazo, J. H. (2004). Turning behaviour induced by stimulation of the 5-HT receptors in the subthalamic nucleus. The European Journal of Neuroscience, 19, 346–355. doi:10.1111/j.0953-816X.2003.03125.x.
Blackburn, T. P., Kemp, J. D., Martin, D. A., & Cox, B. (1984). Evidence that 5-HT agonist-induced rotational behaviour in the rat is mediated via 5-HT1 receptors. Psychopharmacology, 83, 163–165. doi:10.1007/BF00429727.
Blaszczyk, J. W. (2003). Startle response to short acoustic stimuli in rats. Acta Neurobiologiae Experimentalis, 63, 25–30.
Bohlooly, Y. M., Olsson, B., Gritli-Linde, A., Brusehed, O., Isaksson, O. G. P., Ohlsson, C., et al. (2001). Enhanced spontaneous locomotor activity in bovine GH transgenic mice involves peripheral mechanisms. Endocrinology, 142, 4560–4567. doi:10.1210/en.142.10.4560.
Bothe, G. W. M., Bolivar, V. J., Vedder, M. J., & Geistfeld, J. G. (2005). Behavioral differences among fourteen inbred mouse strains commonly used as disease models. Comparative Medicine, 55, 326–334.
Brown-Borg, H. M., Johnson, W. T., Rakoczy, S., & Romanick, M. (2001). Mitochondrial oxidant generation and oxidative stress in Ames dwarf and GH transgenic mice. Journal of the American Aging Association, 24, 85–100.
Cammalleri, M., Cervia, D., Monte, M. D., Martini, D., Langenegger, D., Fehlmann, D., et al. (2006). Compensatory changes in the hippocampus of somatostatin knockout mice: Upregulation of somatostatin receptor 2 and its function in the control of bursting activity and synaptic transmission. The European Journal of Neuroscience, 23, 2404–2422. doi:10.1111/j.1460-9568.2006.04770.x.
Cecim, M., Alvarez-Sanz, M., Van de Kar, L., Milton, S., & Bartke, A. (1996). Increased plasma corticosterone levels in bovine growth hormone (bGH) transgenic mice: Effects of ACTH, GH and IGF-I on in vitro adrenal corticosterone production. Transgenic Research, 5, 187–192. doi:10.1007/BF01969708.
Chartoff, E. H., Marck, B. T., Matsumoto, A. M., Dorsa, D. M., & Palmiter, R. D. (2001). Induction of stereotypy in dopamine-deficient mice requires striatal D1 receptor activation. Proceedings of the National Academy of Sciences of the United States of America, 98, 10451–10456. doi:10.1073/pnas.181356498.
Cirelli, C., Bushey, D., Hill, S., Huber, R., Kreber, R., Ganetzky, B., et al. (2005). Reduced sleep in Drosophila Shaker mutants. Nature, 434, 1087–1092. doi:10.1038/nature03486.
Clark, R. E., Zola, S. M., & Squire, L. R. (2000). Impaired recognition memory in rats after damage to the hippocampus. The Journal of Neuroscience, 20, 8853–8860.
Collin, G. B., Maddatu, T. P., Sen, S., & Naggert, J. K. (2005). Genetic modifiers interact with Cpefat to affect body weight, adiposity, and hyperglycemia. Physiological Genomics, 22, 182–190. doi:10.1152/physiolgenomics.00208.2003.
Cools, A. R. (1972). Neurochemical correlates of the Waltzing-Shaker syndrome in thevariant-Waddler mouse. Psychopharmalogia, 24, 384–396. doi:10.1007/BF00402533.
Crenshaw, E. B., III, Ryan, A., Dillon, S. R., Kalla, K., & Rosenfeld, M. G. (1991). Wocko, a neurological mutant generated in a transgenic mouse pedigree. The Journal of Neuroscience, 11, 1524–1530.
Crespi, F. (1993). Functional in vivo interaction between growth hormone and dopamine systems are correlated to changes in striatal somatostatin levels as determined by voltammetry. Experimental Brain Research, 94, 363–370. doi:10.1007/BF00230196.
Cryns, K., Van Alphen, A. M., Van Spaendonck, M. P., Van de Heyning, P. H., Timmermans, J. P., De Zeeuw, C. I., et al. (2004). Circling behavior in the Ecl mouse is caused by lateral semicircular canal defects. The Journal of Comparative Neurology, 468, 587–595. doi:10.1002/cne.10975.
Cryns, K., Van Spaendonck, M. P., Flothmann, K., van Alphen, A. M., Van De Heyning, P. H., Timmermans, J. P., et al. (2002). Vestibular dysfunction in the epistatic circler mouse is caused by phenotypic interaction of one recessive gene and three modifier genes. Genome Research, 12, 613–617. doi:10.1101/gr.218402.
Cutting, G. R. (2005). Modifier genetics: Cyctic fibrosis. Annual Review of Genomics and Human Genetics, 6, 237–260. doi:10.1146/annurev.genom.6.080604.162254.
Denenberg, V. H., Kim, D. S., & Palmiter, R. D. (2004). The role of dopamine in learning, memory, and performance of a water escape task. Behavioural Brain Research, 148, 173–178. doi:10.1016/S0166-4328(03)00183-9.
Deschaux, O., Bizot, J. C., & Goyffon, M. (1997). Apamin improves learning in an object recognition task in rats. Neuroscience Letters, 222, 159–162. doi:10.1016/S0304-3940(97)13367-5.
Donahue, C. P., Kosik, K. S., & Shors, T. J. (2006). Growth hormone is produced within the hippocampus where it responds to age, sex and stress. Proceedings of the National Academy of Sciences of the United States of America, 103, 6031–6036. doi:10.1073/pnas.0507776103.
Doolittle, D. P. (1963). Two-gene circling in the mouse. Genetics, 48, 887.
Douglas, C. L., Vyazovskiy, V., Southard, T., Chiu, S. Y., Messing, A., Tonnoni, G., et al. (2007). Sleep in Kcna2 knockout mice. BMC Biology, 5, 42. doi:10.1186/1741-7007-5-42.
Espino, A., Calopa, M., Ambrosio, S., Ortola, J., Peres, J., & Navarro, M. A. (1995). CSF somatostatin increase in patients with early parkinsonian syndrome. Journal of Neural Transmission, 9, 189–196. doi:10.1007/BF02259660.
Espinosa, F., Marks, G., Heintz, N., & Joho, R. H. (2004). Increased motor drive and sleep loss in mice lacking Kv3-type potassium channels. Genes Brain & Behavior, 3, 90–100. doi:10.1046/j.1601-183x.2003.00054.x.
Fadel, J., & Deutch, A. Y. (2002). Anatomical substrates of orexin–dopamine interactions: Lateral hypothalamic projections to the ventral tegmental area. Neuroscience, 111, 379–387. doi:10.1016/S0306-4522(02)00017-9.
Fedrowitz, M., Potschka, H., Richter, A., & Loscher, W. (2000). A microdialysis study of striatal dopamine release in the circling rat, a genetic animal model with spontaneous lateralized rotational behavior. Neuroscience, 97, 69–77. doi:10.1016/S0306-4522(00)00040-3.
Fischer, A., Sananbenesi, F., Wang, X., Dobbin, M., & Tsai, L. H. (2007). Recovery of learning and memory is associated with chromatin remodelling. Nature, 447, 178–183. doi:10.1038/nature05772.
Fitzgerald, L. W., Miller, K. L., Ratty, A. K., Glick, S. D., Teitler, M., & Gross, K. W. (1992). Asymmetric elevation of striatal dopamine D2 receptors in the chakragati mouse: Neurobehavioral dysfunction in a trangenic insertional mutant. Brain Research, 580, 18–26. doi:10.1016/0006-8993(92)90922-V.
Fitzgerald, L. W., Ratty, A. K., Teitler, M., Gross, K. W., & Glick, S. D. (1993). Specificity of behavioral and neurochemical dysfunction in the chakragati mouse: A novel genetic model of a movement disorder. Brain Research, 608, 247–258. doi:10.1016/0006-8993(93)91465-5.
Gainetdinov, R. R., Wetsel, W. C., Jones, S. R., Levin, E. D., Jaber, M., & Caron, M. G. (1999). Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science, 283, 397–401. doi:10.1126/science.283.5400.397.
Gerlai, R. (1996). Gene-targeting studies of mammalian behavior: Is it the mutation or the background genotype? Trends in Neurosciences, 19, 177–181. doi:10.1016/S0166-2236(96)20020-7.
Ghelardini, C., Quattrone, A., Galeotti, N., Livi, S., Banchelli, G., Raimondi, L., et al. (2003). Antisense knockdown of the Shaker-like Kv1.1 gene abolishes the central stimulatory effects of amphetamines in mice and rats. Neuropsychopharmacology, 28, 1096–1105.
Giros, B., Jaber, M., Jones, S. R., Wightman, R. M., & Caron, M. G. (1996). Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter. Nature, 379, 606–612. doi:10.1038/379606a0.
Glick, S. D., & Carlson, J. N. (1989). Regional changes in brain dopamine and serotonin metabolism induced by conditioned circling in rats: Effects of water deprivation, learning and individual differences in asymmetry. Brain Research, 504, 231–237. doi:10.1016/0006-8993(89)91362-0.
Grammatikopoulos, G., Pignatelli, M., D’Amico, F., Fiorillo, C., Fresiello, A., & Sadie, A. G. (2002). Selective inhibition of neuronal nitric oxide synthesis reduces hyperactivity and increases non-selective attention in the Naples High-Excitability rat. Behavioural Brain Research, 130, 127–132. doi:10.1016/S0166-4328(01)00424-7.
Hajdu, I., Obal, F., Jr, Fang, J., Krueger, J. M., & Rollo, C. D. (2002). Sleep of transgenic mice producing excess rat growth hormone. American Journal of Physiology: Regulatory, Integrative and Comparative Physiology, 282, R70–R76.
Hathway, G. J., Humphrey, P. P. A., & Kendrick, K. M. (2003). Somatostatin induces striatal dopamine release and contralateral turning behaviour in the mouse. Neuroscience Letters, 358, 127–131. doi:10.1016/j.neulet.2003.09.056.
Hess, E. J., Collins, K. A., & Wilson, M. C. (1996). Mouse model of hyperkinesis implicates SNAP-25 in behavioral regulation. The Journal of Neuroscience, 16, 3104–3111.
Hickman-Davis, J. M. (2001). Implications of mouse genotype for phenotype. News in Physiological Sciences, 16, 19–22.
Hurley, D. L., Birch, D. V., Almond, M. C., Estrada, I. J., & Phelps, C. J. (2003). Reduced hypothalamic neuropeptide Y expression in growth hormone- and prolactin-deficient Ames and Snell dwarf mice. Endocrinology, 144, 4783–4789. doi:10.1210/en.2003-0753.
Isaac, S. O., & Berridge, C. W. (2003). Wake-promoting actions of dopamine D1 and D2 receptor stimulation. The Journal of Pharmacology and Experimental Therapeutics, 307, 386–394. doi:10.1124/jpet.103.053918.
Ishikawa, Y., Shimatsu, A., Murakami, Y., & Imura, H. (1990). Barrel rotation in rats induced by SMS 201-995: Suppression by ceruletide. Pharmacology, Biochemistry and Behavior, 37, 523–526. doi:10.1016/0091-3057(90)90022-A.
Jenner, P. (2003). Oxidative stress in Parkinson’s disease. Annals of Neurology, 53(Suppl. 3), S26–S38. doi:10.1002/ana.10483.
Jinnah, H. A., Jones, M. D., Wojcik, B. E., Rothstein, J. D., Hess, E. J., Friedmann, T., et al. (1999). Influence of strain and age on striatal dopamine loss in a genetic mouse model of Lesch-Nyhan disease. Journal of Neurochemistry, 72, 225–229. doi:10.1046/j.1471-4159.1999.0720225.x.
Johansson, J. O., Larsson, G., Andesson, M., Elmgren, A., Hynsjo, L., Lindahl, A., et al. (1995). Treatment of growth hormone-deficient adults with recombinant human growth hormone increases the concentration of growth hormone in the cerebrospinal fluid and affects neurotransmitters. Neuroendocrinology, 61, 57–66. doi:10.1159/000126813.
Joho, R. H., Street, C., Matsushita, S., & Knopfel, T. (2005). Behavioural motor dysfunction in Kv3-type potassium channel-deficient mice. Genes Brain & Behavior, 5, 472–482. doi:10.1111/j.1601-183X.2005.00184.x.
Kaiser, A., Fedrowitz, M., Ebert, U., Zimmermann, E., Hedrich, H. J., Wedekind, D., et al. (2001). Auditory and vestibular defects in the circling (ci2) rat mutant. The European Journal of Neuroscience, 14, 1129–1142. doi:10.1046/j.0953-816x.2001.01726.x.
Kajiura, L. J., & Rollo, C. D. (1996). The ontogeny of resource allocation in giant transgenic rat growth hormone mice. Canadian Journal of Zoology, 74, 492–507. doi:10.1139/z96-058.
Kamsler, A., & Segal, M. (2003). Hydrogen peroxide modulation of synaptic plasticity. The Journal of Neuroscience, 23, 269–276.
Keithahn, C., & Lerchi, A. (2005). 5-Hydroxytryptophan is a more potent in vitro hydroxyl radical scavenger than melatonin or vitamin C. Journal of Pineal Research, 38, 62–66. doi:10.1111/j.1600-079X.2004.00177.x.
Kiernan, A. E., Erven, A., Voegeling, S., Peters, J., Nolan, P., Hunter, J., et al. (2002). ENU mutagenesis reveals a highly mutable locus on mouse chromosome 4 that affects ear morphogenesis. Mammalian Genome, 13, 142–148.
Kikkawa, Y., Shitara, H., Wakana, S., Kohara, Y., Takada, T., Okamoto, M., et al. (2003). Mutations in a new scaffold protein Sans cause deafness in Jackson shaker mice. Human Molecular Genetics, 12, 453–461. doi:10.1093/hmg/ddg042.
Kim, M. J., Shin, K. S., Chung, Y. B., Jung, K. W., Cha, C. I., & Shin, D. H. (2005). Immunohistochemical study of p47Phox and gp91Phox distributions in rat brain. Brain Research, 1040, 178–186. doi:10.1016/j.brainres.2005.01.066.
Kincaid, A. E. (2001). Spontaneous circling behavior and dopamine neuron loss in a genetically hypothyroid mouse. Neuroscience, 105, 891–898. doi:10.1016/S0306-4522(01)00229-9.
Kiss, J. P., & Vizi, E. S. (2001). Nitric oxide: A novel link between synaptic and nonsynaptic transmission. Trends in Neurosciences, 24, 211–215. doi:10.1016/S0166-2236(00)01745-8.
Kitami, T., & Nadeau, J. H. (2002). Biochemical networking contributes more to genetic buffering in human and mouse metabolic pathways than does gene duplication. Nature Genetics, 32, 191–194. doi:10.1038/ng945.
Koni, P. A., Khanna, R., Chang, M. C., Tang, M. D., Kaczmarek, L. K., Schlichter, L. C., et al. (2003). Compensatory anion currents in Kv1.3 channel-deficient thymocytes. The Journal of Biological Chemistry, 278, 39443–39451. doi:10.1074/jbc.M304879200.
Koshikawa, N., Mori, E., Maruyama, Y., Yatsushige, N., & Kobayashi, M. (1990). Role of dopamine D-1 and D-2 receptors in the ventral striatum in the turning behaviour of rats. European Journal of Pharmacology, 178, 233–237. doi:10.1016/0014-2999(90)90480-T.
Kourie, J. I. (1998). Interaction of reactive oxygen species with ion transport mechanisms. American Journal of Physiology. Cell Physiology, 275, C1–C24.
Koutsilieri, E., Scheller, C., Grunblatt, E., Nara, K., Li, J., & Riederer, P. (2002). Free radicals in Parkinson’s disease. Journal of Neurology, 249(Suppl. 2), II1–II5. doi:10.1007/s00415-002-1201-7.
Kumar, A., Choi, H. K., Renthal, W., Tsankova, N. M., Theobald, D. E. H., Truong, H. T., et al. (2005). Chromatin remodeling is a key mechanism underlying cocaine-induced plasticity in striatum. Neuron, 48, 303–314. doi:10.1016/j.neuron.2005.09.023.
Kume, K., Kume, S., Park, S. K., Hirsh, J., & Jackson, F. R. (2005). Dopamine is a regulator of arousal in the fruit fly. The Journal of Neuroscience, 25, 7377–7384. doi:10.1523/JNEUROSCI.2048-05.2005.
Lachmansingh, E., & Rollo, C. D. (1994). Evidence for a trade-off between growth and behavioural activity in giant ‘Supermice’ genetically engineered with extra growth hormone genes. Canadian Journal of Zoology, 72, 2158–2168. doi:10.1139/z94-288.
Lagziel, A., Ahmed, Z. M., Schultz, J. M., Morell, R. J., Belyantseva, I. A., & Friedman, T. B. (2005). Spatiotemporal pattern and isoform of cadherin 23 in wild type and waltzer mice during inner ear hair cell development. Developmental Biology, 280, 295–306. doi:10.1016/j.ydbio.2005.01.015.
Lemon, J. A., Boreham, D. R., & Rollo, C. D. (2003). A dietary supplement abolishes age-related cognitive decline in transgenic mice expressing elevated free radical processes. Experimental Biology and Medicine, 228, 800–810.
Lemon, J. A., Boreham, D. R., & Rollo, C. D. (2005). A complex dietary supplement extends longevity of mice. Journal of Gerontology, 60A, 275–279.
Lemon, J. A., Rollo, C. D., & Boreham, D. R. (2008b). Elevated DNA damage in a mouse model of oxidative stress: Impacts of ionizing radiation and a protective dietary supplement. Mutagenesis. doi:10.1093/mutage/gen036.
Lemon, J. A., Rollo, C. D., McFarlane, N. M., & Boreham, D. R. (2008a). Radiation-induced apoptosis in mouse lymphocytes is modified by a complex dietary supplement: The effect of genotype and gender. Mutagenesis. doi:10.1093/mutage/gen038.
Lessenich, A., Lindemann, S., Richter, A., Hedrich, H. J., Wedekind, D., Kaiser, A., et al. (2001). A novel black-hooded mutant rat (ci3) with spontaneous circling behavior but normal auditory and vestibular functions. Neuroscience, 107, 615–628. doi:10.1016/S0306-4522(01)00390-6.
Letts, V. A., Valenzuela, A., Dunbar, C., Zheng, Q. Y., Johnson, K. R., & Frankel, W. N. (2000). A new spontaneous mouse mutation in the Kcne1 gene. Mammalian Genome, 11, 831–835. doi:10.1007/s003350010178.
Li, Y., Kelder, B., & Kopchick, J. J. (2001). Identification, isolation, and cloning of growth hormone (GH)-inducible interscapular brown adipose complementary deoyribonuclcleic acid from GH antagonist mice. Endocrinology, 142, 2937–2945. doi:10.1210/en.142.7.2937.
Luo, Y., & Roth, G. S. (2000). The roles of dopamine oxidative stress and dopamine receptor signaling in aging and age-related neurodegeneration. Antioxidants & Redox Signalling, 2, 449–460. doi:10.1089/15230860050192224.
Mahmoud, G. S., & Grover, L. M. (2006). Growth hormone enhances excitatory synaptic transmission in area CA1 of rat hippocampus. Journal of Neurophysiology, 95, 2962–2974. doi:10.1152/jn.00947.2005.
Meis, S., Sosulina, L., Schulz, S., Hollt, V., & Pape, H. C. (2005). Mechanisms of somatostatin-evoked responses in neurons of the rat lateral amygdala. The European Journal of Neuroscience, 21, 755–762. doi:10.1111/j.1460-9568.2005.03922.x.
Meliska, C. J., Bartke, A., Vandergriff, J. L., & Jensen, R. A. (1995). Ethanol and nicotine consumption and preference in transgenic mice overexpressing bovine growth hormone gene. Pharmacology, Biochemistry and Behavior, 50, 563–570. doi:10.1016/0091-3057(94)00345-9.
Meng, W., Tobin, J. R., & Busija, D. W. (1995). Glutamate-induced cerebral vasodilation is mediated by nitric oxide through N-methyl-d-aspartate receptors. Stroke, 26, 857–863.
Michel, P. P., Ruberg, M., & Hirsch, E. (2006). Dopaminergic neurons reduced to silence by oxidative stress: An early step in the death cascade in Parkinson’s disease? Science STKE, 332, pe19. doi:10.1126/stke.3322006pe19.
Mollace, V., Iannone, M., Muscoli, C., Palma, E., Granato, T., Rispoli, V., et al. (2003). The role of oxidative stress in paraquat-induced neurotoxicity in rats: Protection by non peptidyl superoxide dismutase mimetic. Neuroscience Letter, 335, 163–166.
Nadeau, J. H. (2001). Modifier genes in mice and humans. Nature Reviews. Genetics, 2, 165–174. doi:10.1038/35056009.
Nadeau, J. H. (2003a). Modifier genes and protective alleles in humans and mice. Current Opinion in Genetics and Development, 13, 290–295. doi:10.1016/S0959-437X(03)00061-3.
Nadeau, J. H. (2003b). Modifying the message. Science, 301, 927–928. doi:10.1126/science.1088948.
Nadeau, J. H. (2005). Listening to genetic background noise. The New England Journal of Medicine, 353, 1598–1599. doi:10.1056/NEJMe058054.
Nakamura, T., Uramura, K., Nambu, T., Yada, T., Goto, K., Yanagisawa, M., et al. (2000). Orexin-induced hyperlocomotion and stereotypy are mediated by the dopaminergic system. Brain Research, 873, 181–187. doi:10.1016/S0006-8993(00)02555-5.
Narita, M., Nagumo, Y., Hashimoto, S., Narita, M., Khotib, J., Miyatake, M., et al. (2006). Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviours induced by morphine. The Journal of Neuroscience, 26, 398–405. doi:10.1523/JNEUROSCI.2761-05.2006.
Noh, K. M., & Koh, J. Y. (2000). Induction and activation by zinc of NADPH oxidase in cultured cortical neurons and astrocytes. The Journal of Neuroscience, 20, 111–116.
Nolan, P. M., Sollars, P. J., Bohne, B. A., Ewens, W. J., Pickard, G. E., & Bucan, M. (1995). Heterozygosity mapping of partially congenic lines: Mapping of a semidominant neurological mutation, Wheels (Whl), on mouse chromosome 4. Genetics, 140, 245–254.
Palmiter, R. D., Brinster, R. L., & Hammer, R. E. (1982). Dramatic growth of mice that develop from eggs microinjected with metallothionien-growth hormone fusion genes. Nature, 300, 611–615. doi:10.1038/300611a0.
Pan, W., Yu, Y., Cain, C. C., Nyberg, F., Couraud, P. O., & Kastin, A. J. (2005). Permeation of growth hormone across the blood–brain barrier. Endocrinology, 146, 4898–4904. doi:10.1210/en.2005-0587.
Pardo, L. A. (2004). Voltage-gated potassium channels in cell proliferation. Physiology (Bethesda, MD), 19, 285–292. doi:10.1152/physiol.00011.2004.
Perreault, M. L., & Rollo, C. D. (2004). Transgenic growth hormone mice exposed to lifetime constant illumination: Gender-specific effects. Canadian Journal of Zoology, 82, 950–965. doi:10.1139/z04-071.
Pigliucci, M., & Preston, K. (Eds.). (2004). Phenotypic integration: Studying the ecology and evolution of complex phenotypes. New York: Oxford University Press.
Prisino, R., Galeotti, N., Livi, S., Raimondi, L., & Ghelardini, C. (2006). 4-Methyl benzylamine stimulates food consumption and counteracts the hypophagic effects of amphetamine acting on brain Shaker-like Kv1.1 channels. British Journal of Pharmacology, 147, 218–224. doi:10.1038/sj.bjp.0706465.
Propst, F., Rosenberg, M. P., Cork, L. C., Kovatch, R. M., Rauch, S., Westphal, H., et al. (1990). Neuropathological changes in transgenic mice carrying copies of a transcriptionally activated Mos protooncogene. Proceedings of the National Academy of Sciences of the United States of America, 87, 9703–9707. doi:10.1073/pnas.87.24.9703.
Qui, J., Ogus, S., Mounzih, K., Ewart-Toland, A., & Chehab, F. F. (2001). Leptin-deficient mice backcrossed to the BALB/cJ genetic background have reduced adiposity, enhanced fertility, normal body temperature, and severe diabetes. Endocrinology, 142, 3421–3425. doi:10.1210/en.142.8.3421.
Quist, J. F., Barr, C. L., Schachar, R., Roberts, W., Malone, M., Tannock, R., et al. (2003). The serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorder. Molecular Psychiatry, 8, 98–102.
Raimondi, L., Alfarano, C., Pacini, A., Livi, S., Ghelarardini, C., DeSiena, G., et al. (2007). Methylamine-dependent release of nitric oxide and dopamine in the CNS modulates food intake in fasting rats. British Journal of Pharmacology, 150, 1003–1010. doi:10.1038/sj.bjp.0707170.
Ratty, A. K., Matsuda, Y., Elliott, R. W., Chapman, V. M., & Gross, K. W. (1992). Genetic mapping of two DNA markers, D16Ros1 and D16Ros2: Flanking the mutation site in the chakragati mouse, a transgenic insertional mutant. Mammalian Genome, 3, 5–10. doi:10.1007/BF00355834.
Reddy, P. H., Vinod, C., Williams, M., Miller, G., Whhetsel, W. O., Jr, & Tagle, D. A. (1999). Transgenic mice expressing mutated full-length HD cDNA: A paradigm for locomotor changes and selective neuronal loss in Huntington’s disease. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 354, 1035–1045. doi:10.1098/rstb.1999.0456.
Richards, J. B., Sabol, K. E., & Freed, C. R. (1990). Conditioned rotation: A behavioral analysis. Physiology & Behavior, 47, 1083–1087. doi:10.1016/0031-9384(90)90356-9.
Rollo, C. D. (1994). Phenotypes: Their epigenetics, ecology and evolution. London: Chapman and Hall.
Rollo, C. D. (2002). Growth negatively impacts the life span of mammals. Evolution & Development, 4, 55–61. doi:10.1046/j.1525-142x.2002.01053.x.
Rollo, C. D. (2004). Life = Epigenetics, ecology and evolution (L = E3): A review of developmental plasticity and evolution, by Mary Jane West-Eberhard. Evolution & Development, 6, 58–62. doi:10.1111/j.1525-142X.2004.04006.x.
Rollo, C. D. (2005). Review of “Phenotypic integration: Studying the ecology and evolution of complex phenotypes”. In M. Pigliucci & K. Preston (Eds.), Oxford University Press. Quarterly Review of Biology, 80, 112–113.
Rollo, C. D. (2006). Radiation and the regulatory landscape of neo2-Darwinism. Mutation Research, 597, 18–31. doi:10.1016/j.mrfmmm.2005.09.009.
Rollo, C. D. (2007a). Overview of research on giant transgenic mice with emphasis on the brain and aging. In T. Samaras (Ed.), Human body size and the laws of scaling (pp. 235–260). New York: Nova Biomedical Publishers.
Rollo, C. D. (2007b). Technical review of molecular and physiological aspects relevant to size, free radicals and aging. In T. Samaras (Ed.), Human body size and the laws of scaling (pp. 341–357). New York: Nova Biomedical Publishers.
Rollo, C. D. (2007c). Multidisciplinary aspects of regulatory systems relevant to multiple stressors: Aging, xenobiotics and radiation. In C. Mothersill, I. Mosse & S. Seymour (Eds.), Multiple stressors: A challenge for the future (pp. 185–224). New York: Springer.
Rollo, C. D. (2008). Dopamine and aging: Intersecting facets. Neurochemical Research (in press).
Rollo, C. D., Carlson, J., & Sawada, M. (1996). Accelerated aging of giant transgenic mice is associated with elevated free radical processes. Canadian Journal of Zoology, 74, 606–620. doi:10.1139/z96-070.
Rollo, C. D., Foss, J., Lachmansingh, E. I., & Singh, R. (1997a). Behavioural rhythmicity in transgenic growth hormone mice: Tradeoffs, energetics, and sleep-wake cycles. Canadian Journal of Zoology, 75, 20–34.
Rollo, C. D., Kajiura, L., Wylie, B., & D’Souza, S. (1999a). The growth hormone axis, feeding, and central allocative regulation: Lessons from giant transgenic growth hormone mice. Canadian Journal of Zoology, 77, 1861–1873. doi:10.1139/cjz-77-12-1861.
Rollo, C. D., Ko, C. V., Tyerman, J. G. A., & Kajiura, L. J. (1999b). The growth hormone axis and cognition: Empirical results and integrated theory derived from giant transgenic mice. Canadian Journal of Zoology, 77, 1874–1890. doi:10.1139/cjz-77-12-1874.
Rollo, C. D., Lai, M., Whitehead, K., Perreault, M. L., Lemon, J., & Chaudhry, A. M. (2004). Thermoregulation of transgenic growth hormone mice. Canadian Journal of Zoology, 82, 934–949. doi:10.1139/z04-052.
Rollo, C. D., Rintoul, J., & Kajiura, L. J. (1997b). Lifetime reproduction of giant transgenic mice: The energy stress paradigm. Canadian Journal of Zoology, 75, 1336–1345. doi:10.1139/z97-758.
Sakic, B., Szechtman, H., Talangbayan, H., Denburg, S. D., Carbotte, R. M., & Denburg, J. A. (1994). Disturbed emotionality in autoimmune MRL-lpr mice. Physiology & Behavior, 56, 609–617. doi:10.1016/0031-9384(94)90309-3.
Schieke, S. M., Phillips, D., McCoy, J. P., Jr, Aponte, A. M., Shen, R. F., Balaban, R. S., et al. (2006). The mammalian target of rapamycin (mTOR) pathway regulates mitochondrial oxygen consumption and oxidative capacity. The Journal of Biological Chemistry, 281, 27643–27652. doi:10.1074/jbc.M603536200.
Schirmer, M., Nobrega, J. N., Harrison, S. J., & Loscher, W. (2007). Alterations in dopamine D3 receptors in the circling (ci3) rat mutant. Neuroscience, 144, 1462–1469. doi:10.1016/j.neuroscience.2006.11.022.
Schmaulhausen, I. I. (1949). Factors of evolution: The theory of stabilizing selection. Philadelphia: The Blakiston Co.
Schulz, J. B., Lindenau, J., Seyfried, J., & Dichgans, J. (2000). Glutathione, oxidative stress and neurodegeneration. European Journal of Biochemistry, 267, 4904–4911. doi:10.1046/j.1432-1327.2000.01595.x.
Schwarting, R. K. W., & Huston, J. P. (1996). The unilateral 6-hydroxydopamine lesion model in behavioral brain research. Analysis of functional deficits, recovery and treatments. Progress in Neurobiology, 50, 275–331. doi:10.1016/S0301-0082(96)00040-8.
Schweitzer, P., Madamba, S. G., & Siggins, G. R. (1998). Somatostatin increases a voltage-insensitive K+ conductance in rat CA1 hippocampal neurons. Journal of Neurophysiology, 79, 1230–1238.
Serrano, F., Kolluri, N. S., Wientjes, F. B., Card, J. P., & Klann, E. (2003). NADPH oxidase immunoreactivity in the mouse brain. Brain Research, 988, 193–198. doi:10.1016/S0006-8993(03)03364-X.
Smiragalia, D. J., Wu, C., Ellsworth, M. K., Ratty, A. K., Chapman, V. N., & Gross, K. W. (1997). Genetic characterization of the chromosomal rearrangements that accompany the transgene insertion in the Chakragati mouse mutant. Genomics, 45, 572–579. doi:10.1006/geno.1997.4976.
Soderpalm, B., Ericson, M., Bohlooly, M., Engel, J. A., & Tornell, J. (1999). Bovine growth hormone transgenic mice display alterations in locomotor activity and brain monoamine neurochemistry. Endocrinology, 140, 5619–5625. doi:10.1210/en.140.12.5619.
Soghomonian, J. J., & Chesselet, M. F. (1991). Lesions of the dopaminergic nigrostriatal pathway alter preprosomatostatin messenger RNA levels in the striatum, the entopeduncular nucleus and the lateral hypothalamus of the rat. Neuroscience, 42, 49–59. doi:10.1016/0306-4522(91)90149-I.
Sonntag, W. E., Bennett, C., Ingram, R., Donahue, A., Ingraham, J., Chen, H., et al. (2006). Growth hormone and IGF-I modulate local cerebral glucose utilization and ATP levels in a model of adult-onset growth hormone deficiency. American Journal of Physiology. Endocrinology and Metabolism, 291, 604–610. doi:10.1152/ajpendo.00012.2006.
Spielewoy, C., Roubert, C., Hamon, M., Nosten-Bertrand, M., Betancur, C., & Giros, B. (2000). Behavioural disturbances associated with hyperdopaminergia in dopamine-transporter knockout mice. Behavioural Pharmacology, 11, 279–290.
Stackman, R. W., Hammond, R. S., Linardatos, E., Gerlach, A., Maylie, J., & Adelman, J. P. (2002). Small conductance Ca2+-activated K+ channels modulate synaptic plasticity and memory encoding. The Journal of Neuroscience, 22, 10163–10171.
Stearns, S. C. (2000). Life history evolution: Successes, limitations, and prospects. Naturwissenschaften, 87, 476–486. doi:10.1007/s001140050763.
Steger, R. W., Bartke, A., & Cecim, M. (1993). Premature ageing in transgenic mice expressing different growth hormone genes. Journal of Reproduction and Fertility. Supplement, 46, 61–75.
Steger, R. W., Bartke, A., Parkening, T. A., Collins, T., Buonomos, F. C., Tang, K., et al. (1991). Effects of heterologous growth hormones on hypothalamic and pituitary function in transgenic mice. Neuroendocrinology, 53, 365–372. doi:10.1159/000125743.
Strittmatter, M., Isenberg, E., Grauer, M. T., Hamann, G., & Schimrigk, K. (1996). CSF substance P, somatostatin and monoaminergic transmitter metabolites in patients with narcolepsy. Neuroscience Report, 218, 99–102.
Sutcliffe, J. D., & de Lecea, L. (2002). The hypocretins: Setting the arousal threshold. Nature Reviews. Neuroscience, 3, 339–349. doi:10.1038/nrn808.
Svensson, J., Soderpalm, B., Sjogren, K., Engel, J., & Ohlsson, C. (2005). Liver-derived IGF-1 regulates exploratory activity in old mice. American Journal of Physiology. Endocrinology and Metabolism, 289, E455–E473. doi:10.1152/ajpendo.00425.2004.
Szczypka, M. S., Zhou, Q. Y., & Palmiter, R. D. (1998). Dopamine-stimulated sexual behavior is testosterone dependent in mice. Behavioral Neuroscience, 112, 1229–1235. doi:10.1037/0735-7044.112.5.1229.
Szechtman, H. (1988). Effect of dopamine receptor agonist apomorphine on sensory input. Naunyn-Schmiedeberg’s Archives of Pharmacology, 338, 489–496. doi:10.1007/BF00179319.
Sziraki, I., Mohanakumar, K. P., Rauhala, P., Kim, H. G., Yeh, K. J., & Chiueh, C. C. (1998). Manganese: A transition metal protects nigrostriatal neurons from oxidative stress in the iron-induced animal model of Parkinsonism. Neuroscience, 85, 1101–1111. doi:10.1016/S0306-4522(97)00660-X.
Tang, Y. P., Shimizu, E., Dube, G. R., Rampon, C., Kerchner, G. A., Zhuo, M., et al. (1999). Genetic enhancement of learning and memory in mice. Nature, 401, 63–69. doi:10.1038/43432.
Taylor, B. A. (1976). Epistatic circling gene of C57L/J. Mouse News Letter, 55, 17.
Tejada-Simon, M. V., Serrano, F., Villasana, L. E., Kanterewicz, B. I., Wu, G. Y., Quinn, M. T., et al. (2005). Synaptic localization of a functional NADPH oxidase in the mouse hippocampus. Molecular and Cellular Neurosciences, 29, 97–106. doi:10.1016/j.mcn.2005.01.007.
Torres, G., Hallas, B. H., Vernace, V. A., Jones, C., Gross, K. W., & Horowitz, J. M. (2004). A neurobehavioral screening of the ckr mouse mutant: Implications for an animal model of schizophrenia. Brain Research Bulletin, 62, 315–326. doi:10.1016/j.brainresbull.2003.09.020.
Truett, G. E., Brock, J. W., Lidl, G. M., & Kloster, C. A. (1994). Stargazer (stg), new deafness mutant in the Zucker rat. Laboratory Animal Science, 44, 595–599.
Vezzani, A., & Hoyer, D. (1999). Brain somatostatin: A candidate inhibitory role in seizures and epileptogenesis. The European Journal of Neuroscience, 11, 3767–3776.
Vyazovskiy, V. V., Deboer, T., Rudy, B., Lau, D., Borbely, A. A., & Tobler, I. (2002). Sleep EEG in mice that are deficient in the potassium channel subunit K.v.3.2. Brain Research, 947, 204–211. doi:10.1016/S0006-8993(02)02925-6.
Waddington, C. H. (1957). The strategy of the genes. London: George Allen and Unwin.
Wagner, E. F., Covarrubias, L., Stewart, T. A., & Mintz, B. (1983). Prenatal lethalities in mice homozygous for human growth hormone gene sequences integrated in the germ line. Cell, 35, 647–655. doi:10.1016/0092-8674(83)90097-1.
Weaver, I. C. G., Champagne, F. A., Brown, S. E., Dymov, S., Sharma, S., Meaney, M. J., et al. (2005). Reversal of maternal programming of stress responses in adult offspring through methyl supplementation: Altering epigenetic marking later in life. Neuroscience, 25, 11045–11054. doi:10.1523/JNEUROSCI.3652-05.2005.
Weimar, W. R., Lane, P. W., & Sidman, R. L. (1982). Vibrator (vb): A spinocerebellar system degeneration with autosomal recessive inheritance in mice. Brain Research, 251, 357–364. doi:10.1016/0006-8993(82)90754-5.
Weltman, A. S., Sackler, A. M., Lewis, A. S., & Johnson, L. (1970). Metabolism rate biochemical and endocrine alterations in male whirler mice. Physiology & Behavior, 5, 17–22. doi:10.1016/0031-9384(70)90006-5.
Wenthold, R. J., & Gulley, R. L. (1978). Glutamic acid and aspartic acid in the cochlear nucleus of the waltzing Guinea pig. Brain Research, 158, 295–302. doi:10.1016/0006-8993(78)90676-5.
West-Eberhard, M. J. (2003). Developmental plasticity and evolution. New York: Oxford University Press.
Wilson, M. C. (2000). Coloboma mouse mutant as an animal model of hyperkinesis and attention deficit hyperactivity disorder. Neuroscience and Biobehavioral Reviews, 24, 51–57. doi:10.1016/S0149-7634(99)00064-0.
Wonderlin, W. F., & Strobl, J. S. (1996). Potassium channels, proliferation and G1 progression. The Journal of Membrane Biology, 154, 91–107. doi:10.1007/s002329900135.
Xu, R., Roh, S. G., Loneragan, K., Pullar, M., & Chen, C. (1999). Human GHRH reduces voltage-gated K+ currents via a non-cAMP-dependent but PKC-mediated pathway in human GH adenoma cells. The Journal of Physiology, 520, 697–707. doi:10.1111/j.1469-7793.1999.00697.x.
Yamanaka, A., Beuckmann, C. T., Willie, J. T., Hara, J., Tsujino, N., Mieda, M., et al. (2003). Hypothalamic orexin neurons regulate arousal according to energy balance in mice. Neuron, 38, 701–713. doi:10.1016/S0896-6273(03)00331-3.
Young, K. A., Berry, M. L., Mahaffey, C. L., Saionz, J. R., Hawes, N. L., Chang, B., et al. (2002). Fierce: A new mouse deletion of Nr2e1; violent behaviour and ocular abnormalities are background dependent. Behavioural Brain Research, 132, 145–158. doi:10.1016/S0166-4328(01)00413-2.
Zavitsanou, K., Triarhou, L. C., Kouvelas, E. D., Mitsacos, A., Palacios, J. M., & Mengod, G. (2002). Somatostatin, cholecystokinin and neuropeptide Y mRNAs in normal and weaver mouse brain. Journal of Neural Transmission, 109, 1337–1351. doi:10.1007/s00702-002-0759-7.
Zhang, Y., Vilaythong, A. P., Yoshor, D., & Noebels, J. L. (2004). Elevated thalamic low-voltage-activated currents precede the onset of absence epilepsy in the SNAP25-deficient mouse mutant Coloboma. The Journal of Neuroscience, 24, 5239–5248. doi:10.1523/JNEUROSCI.0992-04.2004.
Ziegler, M., & Szechtman, H. (1988). Differences in the behavioral profile of circling under amphetamine and apomorphine in rats with unilateral lesions of the substantia nigra. Behavioral Neuroscience, 102, 276–288. doi:10.1037/0735-7044.102.2.276.
Acknowledgements
The authors acknowledge that they have no conflicts of interest. The Natural Sciences and Engineering Research Council of Canada (RGPIN A0544) and Canadian Institutes for Health Research (MOP-64424) provided funding. Dr. Jack Rosenfeld provided assistance and training for the HPLC. We thank our editor (Dr. B. Hallgrimsson) and two anonymous reviewers who emphasised the value of demonstrating that selection had occurred in the transgenic growth hormone mice and for other critical comments that greatly improved this manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chaudhry, A.M., Marsh-Rollo, S.E., Aksenov, V. et al. Modifier Selection by Transgenes: The Case of Growth Hormone Transgenesis and Hyperactive Circling Mice. Evol Biol 35, 267–286 (2008). https://doi.org/10.1007/s11692-008-9036-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11692-008-9036-5